Ainos, Inc. (AIMD) vs Medicus Pharma Ltd. Common Stock (MDCX)
A side-by-side comparison of Ainos, Inc. and Medicus Pharma Ltd. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIMD
Ainos, Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 12:07 PM EDT
MDCX
Medicus Pharma Ltd. Common Stock
$0.16HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — AIMD vs MDCX
growth of $100 · dividends reinvested · last 2yAIMD -45.9% (-26.5%/yr)MDCX -93.7% (-74.9%/yr)AIMD compounded faster over this window
Log scale — wide-divergence pair
AIMD MDCX
AIMD vs MDCX: by the numbers
- •MDCX is the larger company ($10M vs $10M market cap).
- •Both run net losses; MDCX's is the smaller (0.00% vs -106283.32% net margin).
Metrics side by side
Valuation
| Metric | AIMD | MDCX |
|---|---|---|
| P/S ratio | 717.50 | N/A |
| P/B ratio | 2.97 | N/A |
Profitability
| Metric | AIMD | MDCX |
|---|---|---|
| Gross margin | -3767.20% | 0.00% |
| Operating margin | -11268.32% | 0.00% |
| Net margin | -106283.32% | 0.00% |
| ROE | -440.15% | N/A |
| ROIC | -80.51% | -269.16% |
Growth (annualized)
| Metric | AIMD | MDCX |
|---|---|---|
| Revenue CAGR (5Y) | 49.62% | N/A |
| Total return CAGR (5Y) | -58.50% | N/A |
Go deeper
Dig into the metrics
Ainos ROEMedicus Pharma Ltd. Common Stock ROEAinos operating marginMedicus Pharma Ltd. Common Stock operating marginAinos revenue growthMedicus Pharma Ltd. Common Stock revenue growthAinos free cash flowMedicus Pharma Ltd. Common Stock free cash flow
Ainos & Medicus Pharma Ltd. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.